Siafarikas Aris, Watts Katie, Beye Petra, Jones Timothy W, Davis Elizabeth A, Green Daniel J
Department of Endocrinology and Diabetes, Princess Margaret Hospital, Subiaco, WA 6007, Australia.
Clin Sci (Lond). 2004 Aug;107(2):191-6. doi: 10.1042/CS20040004.
The aim of the present study was to investigate the impact of an oral glucose load on circulating insulin and glucose levels and arterial function in healthy non-diabetic subjects. Thirty-nine non-obese, healthy subjects (24 female, 15 male), aged 21.0+/-1.8 years of age, were randomly assigned to undergo either an OGTT (oral glucose tolerance test; 75 g of glucose) or administration of a placebo. Analyses of lipids, liver function and HbA(1c) (glycated haemoglobin) at baseline revealed results which were within the standard reference range. Insulin and glucose levels as well as vascular function [FMD (flow-mediated dilation)] were measured at 0, 60 and 120 min. Compared with baseline, the control subjects did not exhibit any significant changes in glucose or insulin levels, whereas, in the OGTT group, blood glucose levels at both 60 (5.4+/-1.7 mmol/l) and 120 (5.0+/-1.1 mmol/l) min increased significantly relative to baseline (4.1+/-0.4 mmol/l; both P<0.001) and, similarly, insulin levels were higher at both 60 (30.1+/-21.3 m-units/l) and 120 (34.9+/-23.6 m-units/l) min compared with baseline (4.7+/-4.3 m-units/l; both P<0.001). Although blood glucose and insulin levels changed, FMD did not significantly differ between time-points or between groups. In summary, despite significantly elevated glucose and insulin concentrations in these subjects, we observed no change in vascular function, suggesting that acute elevations of glucose and insulin within the clinically normal range are not associated with impaired vascular function in vivo.
本研究的目的是调查口服葡萄糖负荷对健康非糖尿病受试者循环胰岛素和葡萄糖水平以及动脉功能的影响。39名非肥胖健康受试者(24名女性,15名男性),年龄21.0±1.8岁,被随机分配接受口服葡萄糖耐量试验(OGTT;75克葡萄糖)或服用安慰剂。基线时对血脂、肝功能和糖化血红蛋白(HbA1c)的分析结果在标准参考范围内。在0、60和120分钟时测量胰岛素和葡萄糖水平以及血管功能[血流介导的血管舒张(FMD)]。与基线相比,对照组受试者的葡萄糖或胰岛素水平没有显著变化,而在OGTT组中,60分钟(5.4±1.7毫摩尔/升)和120分钟(5.0±1.1毫摩尔/升)时的血糖水平相对于基线(4.1±0.4毫摩尔/升)均显著升高(均P<0.001),同样,60分钟(30.1±21.3毫单位/升)和120分钟(34.9±23.6毫单位/升)时的胰岛素水平与基线(4.7±4.3毫单位/升)相比也更高(均P<0.001)。尽管血糖和胰岛素水平发生了变化,但FMD在各时间点之间或组间没有显著差异。总之,尽管这些受试者的葡萄糖和胰岛素浓度显著升高,但我们观察到血管功能没有变化,这表明临床正常范围内葡萄糖和胰岛素的急性升高与体内血管功能受损无关。